LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.26 | 27.76 | 3018 | 6465 | 0.4668 | 0.8153 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 63.26 | 27.76 | 6279 | 6465 | 0.9711 | 0.9926 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.97 | 27.76 | 5621 | 6656 | 0.8444 | 0.9577 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.97 | 27.76 | 5644 | 6656 | 0.8479 | 0.9587 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.97 | 27.76 | 3195 | 6656 | 0.4800 | 0.8227 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 64.97 | 27.76 | 6471 | 6656 | 0.9721 | 0.9929 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 66.67 | 27.76 | 5817 | 6695 | 0.8688 | 0.9648 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 66.67 | 27.76 | 5844 | 6695 | 0.8728 | 0.9659 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 66.67 | 27.76 | 3240 | 6695 | 0.4839 | 0.8247 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 66.67 | 27.76 | 6759 | 6695 | 1.0095 | 1.0024 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 68.37 | 27.76 | 5992 | 6879 | 0.8710 | 0.9656 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 68.37 | 27.76 | 6023 | 6879 | 0.8755 | 0.9669 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 68.37 | 27.76 | 3352 | 6879 | 0.4873 | 0.8271 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 68.37 | 27.76 | 6911 | 6879 | 1.0046 | 1.0012 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.08 | 27.76 | 6120 | 6849 | 0.8935 | 0.9719 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.08 | 27.76 | 6149 | 6849 | 0.8977 | 0.9730 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.08 | 27.76 | 2979 | 6849 | 0.4349 | 0.8011 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 70.08 | 27.76 | 7108 | 6849 | 1.0377 | 1.0093 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.78 | 27.76 | 6313 | 6893 | 0.9158 | 0.9780 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.78 | 27.76 | 6339 | 6893 | 0.9196 | 0.9790 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.78 | 27.76 | 3258 | 6893 | 0.4726 | 0.8202 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.78 | 27.76 | 7372 | 6893 | 1.0695 | 1.0170 | MN20160318_Q01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.48 | 27.76 | 6452 | 6957 | 0.9273 | 0.9812 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.48 | 27.76 | 6483 | 6957 | 0.9318 | 0.9823 | MN20160318_Q01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.48 | 27.76 | 3584 | 6957 | 0.5151 | 0.8403 | MN20160318_Q01 | M13 |